medtronic-infuse-bone-graft-infographic-side-effects-history-lawsuit
MEDTRONIC INFUSE BONE GRAFT LAWSUIT TIMELINE Side Effects Include: Cancer NOT APPROVED Sexual Side Effects Uncontrolled Bone Growth APPROVED Infuse is approved for anterior approach lumbar fusion. Infuse is not approved for the following spinal surgeries: Lateral/Posterior approach Lumbar Fusion Surgeries Surgery on the Neck or Cervical Spine Neck/Throat Swelling Nerve Injuries 2002: 2008: 2011: The FDA approved Infuse for one type of spinal surgery. The FDA issues an advisory of serious complications associated with Infuse. The spine journal publishes a study on Medtronic complications stating that Medtronic researchers Failed to Report Complications Off-label Uses total 82% of all uses 280 Reports of side effects due to the INFUSE Bone Graft System 2004: 38 Reports of life threatening side effects Medtronic Promotes Off-Label use of the Infuse Bone Graft System. 2012: $800 million 3/4 Three quarters off all side effects are reported from off-label uses DOJ closes the investigation into Off-Label use of Infuse. Investigators found that Medtronic paid authors to write published studies of Infuse. The DOJ began investigating Medtronic for Total sales of the INFUSE bone graft system were a staggering 800 million. Illegally Advertising 85% the Medtronic Infuse Bone Graft. $$$$ Medtronic Failed to reveal that 85% of sales were dependent on off-label sales. $40 million Call d'Oliveira & Associates at Medtronic Pays 15 Doctors over 60 million to promote off-label uses of INFUSE Medtronic settles two lawsuits on Infuse for 40 Million Dollars. 1-800-992-6878 for a free consultation MEDTRONIC INFUSE BONE GRAFT LAWSUIT TIMELINE Side Effects Include: Cancer NOT APPROVED Sexual Side Effects Uncontrolled Bone Growth APPROVED Infuse is approved for anterior approach lumbar fusion. Infuse is not approved for the following spinal surgeries: Lateral/Posterior approach Lumbar Fusion Surgeries Surgery on the Neck or Cervical Spine Neck/Throat Swelling Nerve Injuries 2002: 2008: 2011: The FDA approved Infuse for one type of spinal surgery. The FDA issues an advisory of serious complications associated with Infuse. The spine journal publishes a study on Medtronic complications stating that Medtronic researchers Failed to Report Complications Off-label Uses total 82% of all uses 280 Reports of side effects due to the INFUSE Bone Graft System 2004: 38 Reports of life threatening side effects Medtronic Promotes Off-Label use of the Infuse Bone Graft System. 2012: $800 million 3/4 Three quarters off all side effects are reported from off-label uses DOJ closes the investigation into Off-Label use of Infuse. Investigators found that Medtronic paid authors to write published studies of Infuse. The DOJ began investigating Medtronic for Total sales of the INFUSE bone graft system were a staggering 800 million. Illegally Advertising 85% the Medtronic Infuse Bone Graft. $$$$ Medtronic Failed to reveal that 85% of sales were dependent on off-label sales. $40 million Call d'Oliveira & Associates at Medtronic Pays 15 Doctors over 60 million to promote off-label uses of INFUSE Medtronic settles two lawsuits on Infuse for 40 Million Dollars. 1-800-992-6878 for a free consultation
medtronic-infuse-bone-graft-infographic-side-effects-history-lawsuit
Source
http://www.g...-graft.htmCategory
OtherGet a Quote